Delivery Order SPE2DB22D2007-SPE2DB24FJ6CA

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,653.06 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Spiriva Respimat 2.5 mcg inhalation medication, with a performance period through May 2, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,050.98 contract is for the supply of Spiriva Respimat 2.5 mcg inhalation medication, with a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical that serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, valued at $38,073.44, for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This contract represents a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,145.56, is for the supply of Spiriva Respimat 2.5 mcg inhalation medication in a 4 gram quantity. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,926.08 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of Spiriva Respimat 2.5 mcg inhalation medication in support of military treatment programs and facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,428.27, is for the procurement of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a medical product used for respiratory conditions. The Delivery Order was issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 2.5 MCG INH 4GM. The $1,533.26 fixed-price contract has an ultimate completion date of April 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
The U.S. government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Spiriva Respimat 2.5 MCG INH 4GM medication to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $36,215.85, has a performance period ending on March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and the contract does not have a set-aside designation. This delivery order is part of a larger...
This is a $1,042.65 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication. It is a firm fixed-price contract with a completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4 gram packages, with a total ceiling value of $1,668.24 and a period of performance through March 3, 2025. The contract is an open competition award, with no set-aside designation. AmerisourceBergen holds a significant...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ6CA
    Delivery Order

This delivery order was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,962.60 fixed-price contract is for the supply of Spiriva Respimat 2.5 MCG Inhalation Medication in 4 Gram quantities. It is not a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

Generated 12/12/24, 10:51 AM